| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |